Aardvark Therapeutics (AARD) Misses Q4 EPS by 81c
Get Alerts AARD Hot Sheet
Join SI Premium – FREE
Aardvark Therapeutics (NASDAQ: AARD) reported Q4 EPS of ($0.81).
For earnings history and earnings-related data on Aardvark Therapeutics (AARD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Weighs Tapping Musk For Equity Investment - Semafor
- Espey Manufacturing (ESP) Tops Q4 EPS by 24c
- CNA Financial (CNA) 2800 contracts of October 50 calls
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share